Menu
GeneBe

9-99828473-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_006981.4(NR4A3):​c.431C>G​(p.Thr144Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

NR4A3
NM_006981.4 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.61
Variant links:
Genes affected
NR4A3 (HGNC:7982): (nuclear receptor subfamily 4 group A member 3) This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcriptional activator. The protein can efficiently bind the NGFI-B Response Element (NBRE). Three different versions of extraskeletal myxoid chondrosarcomas (EMCs) are the result of reciprocal translocations between this gene and other genes. The translocation breakpoints are associated with Nuclear Receptor Subfamily 4, Group A, Member 3 (on chromosome 9) and either Ewing Sarcome Breakpoint Region 1 (on chromosome 22), RNA Polymerase II, TATA Box-Binding Protein-Associated Factor, 68-KD (on chromosome 17), or Transcription factor 12 (on chromosome 15). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
STX17-DT (HGNC:51174): (STX17 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07438925).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NR4A3NM_006981.4 linkuse as main transcriptc.431C>G p.Thr144Ser missense_variant 3/8 ENST00000395097.7
NR4A3NM_173200.3 linkuse as main transcriptc.464C>G p.Thr155Ser missense_variant 4/9
NR4A3NM_173199.4 linkuse as main transcriptc.431C>G p.Thr144Ser missense_variant 3/5
NR4A3XM_017015162.2 linkuse as main transcriptc.431C>G p.Thr144Ser missense_variant 4/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NR4A3ENST00000395097.7 linkuse as main transcriptc.431C>G p.Thr144Ser missense_variant 3/81 NM_006981.4 P1Q92570-1
STX17-DTENST00000655615.1 linkuse as main transcriptn.268+10513G>C intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 18, 2023The c.464C>G (p.T155S) alteration is located in exon 4 (coding exon 2) of the NR4A3 gene. This alteration results from a C to G substitution at nucleotide position 464, causing the threonine (T) at amino acid position 155 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
16
DANN
Benign
0.54
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.29
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.76
T;T;T;.
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.074
T;T;T;T
MetaSVM
Benign
-0.38
T
MutationAssessor
Benign
0.55
N;N;.;.
MutationTaster
Benign
0.91
D;D;D
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-1.2
N;N;.;N
REVEL
Benign
0.21
Sift
Benign
1.0
T;T;.;T
Sift4G
Benign
0.59
T;T;T;T
Polyphen
0.0030
B;B;B;B
Vest4
0.21
MutPred
0.23
Loss of relative solvent accessibility (P = 0.0186);Loss of relative solvent accessibility (P = 0.0186);.;.;
MVP
0.69
ClinPred
0.076
T
GERP RS
2.1
Varity_R
0.091
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372573982; hg19: chr9-102590755; API